New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
11:11 EDTARIA, ICPT, EXEL, CREE, YRCWOptions with decreasing implied volatility: ICPT YRCW EXEL ARIA CREE
News For ICPT;YRCW;EXEL;ARIA;CREE From The Last 14 Days
Check below for free stories on ICPT;YRCW;EXEL;ARIA;CREE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2014
10:04 EDTCREECree April weekly volatility elevated at 100 into Q1 and outlook
Cree April weekly call option implied volatility is at 100, June is at 48, September at 43; compared to its 26-week average of 42 according to Track Data, suggesting larger near term price movement into the expected release of Q1 results on April 24.
10:00 EDTCREEOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:58 EDTCREECree upgraded to Buy from Hold at Needham
Subscribe for More Information
April 14, 2014
08:59 EDTICPTOn The Fly: Pre-market Movers
Subscribe for More Information
April 12, 2014
20:04 EDTICPTIntercept reports additional positive data from POISE trial at EASL
Subscribe for More Information
April 11, 2014
09:08 EDTICPTIntercept announces OCA preclinical study data
Subscribe for More Information
April 10, 2014
12:54 EDTCREECree upgraded at DA Davidson
Subscribe for More Information
12:32 EDTCREECree upgraded to Buy from Neutral at DA Davidson
Subscribe for More Information
April 9, 2014
09:35 EDTCREECree shares mentioned positively at Northland Securities
Subscribe for More Information
07:23 EDTICPTEuropean Association for the Study of the Liver to hold annual meeting
Subscribe for More Information
April 8, 2014
11:03 EDTICPTPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
April 7, 2014
10:26 EDTCREECree May volatility elevated at 58 on tight five-month price movement
Subscribe for More Information
10:07 EDTARIAARIAD has a conference call hosted by JPMorgan
JPMorgan Analysts Meacham and Kasimov will host a conference call with CEO Harvey Berger on April 10 at 10 am.
April 4, 2014
10:11 EDTICPTIntercept to present on POISE trial at EASL meeting
Subscribe for More Information
06:18 EDTEXELPiper says time to buy shares of Exelixis
Piper Jaffray believes it's time to buy shares of Exelixis with the stock down 56% from the close on March 25. Piper thinks shares at current levels have "washed out" cabozantinib in castration-resistant prostate cancer. It reiterates an Overweight rating on Exelixis with an $11 price target.
06:02 EDTICPTIntercept 1M share Secondary priced at $320.00
BofA/Merrill, Citigroup and Goldman acted as joint book running managers for the offering.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use